Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.3%

2 terminated out of 38 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

8%

3 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed with results

Key Signals

4 with results88% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (15)
P 1 (3)
P 3 (1)
P 4 (2)

Trial Status

Completed15
Unknown9
Recruiting7
Withdrawn3
Terminated2
Active Not Recruiting2

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (38)

Showing 20 of 20 trials
NCT07502989RecruitingPrimary

Muscle Health Measurements Using Electrical Impedance Myography

NCT00937001Not ApplicableActive Not RecruitingPrimary

Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness

NCT01353430Recruiting

Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)

NCT03660969Active Not RecruitingPrimary

Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease

NCT05599568Not ApplicableRecruitingPrimary

Repeated Bout Effect i Neuromuscular Diseases

NCT06837467Not ApplicableCompletedPrimary

Differential SERCA Expression in Laryngeal Muscles

NCT06374719Recruiting

WiTNNess - TNNT1 Myopathy Natural History Study

NCT04678635Not ApplicableRecruitingPrimary

Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

NCT03749538Not ApplicableRecruitingPrimary

Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

NCT03998540RecruitingPrimary

Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy

NCT04881214Not ApplicableUnknown

COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program

NCT02104921Completed

Innovative Ultrasound Technology in Neuromuscular Disease

NCT02765828CompletedPrimary

Identification of Tongue Involvement in Late-Onset Pompe Disease

NCT04941079Unknown

Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients :a Prospective Observational Study

NCT03751644Not ApplicableCompleted

Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies

NCT01642056Phase 1Completed

EPI-743 for Metabolism or Mitochondrial Disorders

NCT01547767CompletedPrimary

Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy

NCT02247895Not ApplicableTerminated

Treatment of Muscle Weakness in Critically Ill Patients

NCT02706314Completed

Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks.

NCT03042286UnknownPrimary

SAPhIRE Statin Adverse Drug Reaction

Scroll to load more

Research Network

Activity Timeline